Evaluation of andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) for reversal of rivaroxaban‐ and apixaban‐associated intracranial hemorrhages-Reference-Cited by-同舟云学术

Evaluation of andexanet alfa and four‐factor prothrombin complex concentrate (4F‐PCC) for reversal of rivaroxaban‐ and apixaban‐associated intracranial hemorrhages

Published:2020-05-12 Issue:7 Volume:18 Page:1637-1647
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Barra Megan E.¹,Das Alvin S.²,Hayes Bryan D.¹³,Rosenthal Eric S.²,Rosovsky Rachel P.⁴,Fuh Lanting¹,Patel Aman B.⁵,Goldstein Joshua N.³,Roberts Russel J.¹

Affiliation:

1. Department of Pharmacy Massachusetts General Hospital Boston MA USA

2. Department of Neurology Massachusetts General Hospital Harvard Medical School Boston MA USA

3. Department of Emergency Medicine Massachusetts General Hospital Harvard Medical School Boston MA USA

4. Department of Medicine Division of Hematology Massachusetts General Hospital Harvard Medical School Boston MA USA

5. Department of Neurosurgery Massachusetts General Hospital Harvard Medical School Boston MA USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14838

Reference48 articles.

1. Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients

2. Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis

3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

4. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents

5. Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and Future Trends in the Diagnosis and Management of Intracerebral Hemorrhage;Neurologic Clinics;2024-08

2. Reprint of: Four-factor prothrombin complex concentrate versus andexanet alfa for direct oral anticoagulant reversal;Journal of the American Pharmacists Association;2024-08

3. Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation;Expert Review of Neurotherapeutics;2024-07-22

4. Andexanet alpha versus four-factor prothrombin complex concentrate in DOACs anticoagulation reversal: an updated systematic review and meta-analysis;Critical Care;2024-07-05

5. Traumatic Brain Injury in Patients under Anticoagulant Therapy: Review of Management in Emergency Department;Journal of Clinical Medicine;2024-06-24